Key statistics
As of last trade, Tiziana Life Sciences Ltd (0RP:BER) traded at 0.865, 121.79% above the 52 week low of 0.39 set on Mar 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.865 |
---|---|
High | 0.865 |
Low | 0.865 |
Bid | 0.82 |
Offer | 0.915 |
Previous close | 0.85 |
Average volume | 555.56 |
---|---|
Shares outstanding | 103.09m |
Free float | 63.74m |
P/E (TTM) | -- |
Market cap | 97.92m USD |
EPS (TTM) | -0.1726 USD |
Data delayed at least 15 minutes, as of Oct 10 2024 11:12 BST.
More ▼
Announcements
- Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
- Tiziana Life Sciences Appoints New Chief Executive Officer
- Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
- Tiziana Life Sciences Granted FDA Fast Track Designation
- Tiziana Receives $3.4 Million in Non-Dilutive Funding
- Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
- FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
- Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
- Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
- Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
More ▼